MDS can progress to AML. I am in Cycle 26 of treated at UCLA and have Azacitidine Injections and Venetoclax pills. This treatment was originally approved for AML and recently for MDS. The treatment can be the same. Being treated at MD Anderson is excellent. Like UCLA it is a "Center of Excellence" in relation to cancer. Fortunately, you are young enough to be considered for a stem cell procedure. Currently, what is your treatment for MDS.

The best to you.

Alan

Jeff, I also had MDS, subtype EB2 and it has since progressed to AML. From everything I’ve read, MDS, subtype EB2 is high risk for progressing to AML.

Thank you Alan, I'm already in treatment and just finishing my first cycle of chemotherapy in a clinical trail at MD Anderson.
My curiosity in the question is it's just a few percentage point difference in blast count between MDS-IB2 and AML.
In this trial, the treatment is the same for either, with stem cell replacement being the goal for cure.
I appreciate your help.

Jeff,

There is a difference between "diagnosis and treatment". MDS-EB2 is a diagnosis that relates to the number of blasts cells in your bone marrow. MDS-EB2 is not AML. The ICD -10-CM diagnostic billing code for MDS is D46-Z (https://icdlist.com/icd-10/d46z). The ICD code is for diagnostic and treatment billing to your insurance company and/or Medicare.

I suggest you obtain copies of your blood tests (CBC & CMP) plus Aspirate and Bone Marrow Procedure(s) from your medical provider.

Alan